Epigenetic perspectives on cancer chemotherapy response

Area of Science:

• Oncology
• Epigenetics
• Pharmacology

Background:

• Epigenetic programs play a crucial role in cancer development.
• The influence of epigenetics on anticancer drug response remains incompletely understood.
• Epigenetic drugs are a rapidly developing area in cancer treatment.

Purpose of the Study:

• To elucidate how epigenetic modifications impact anticancer drug responses.
• To review major epigenetic regulatory mechanisms and their role in cancer.
• To promote rational clinical use of anticancer drugs and guide epigenetic drug development.

Main Methods:

• Review of major epigenetic regulatory mechanisms: DNA methylation, miRNA regulation, and histone modification.
• Analysis of epigenetic involvement in genes controlling drug absorption, distribution, metabolism, and excretion (ADME).
• Examination of epigenetic regulation in cancer pathological progression.

Main Results:

• Epigenetic modifications regulate genes involved in drug ADME, thus affecting drug bioavailability and efficacy.
• Epigenetic changes contribute to cancer progression, influencing overall response to therapy.
• Major epigenetic mechanisms (DNA methylation, miRNA, histone modification) are implicated in drug response.

Conclusions:

• Epigenetic modifications significantly influence anticancer drug responses through various mechanisms.
• A deeper understanding of epigenetics is essential for optimizing cancer treatment strategies.
• Targeting epigenetic regulation holds promise for novel anticancer drug development and personalized medicine.